Empros will hold its annual general meeting on the 5th of May. Documents requested by shareholders no later than 26th of April 2022, will be published here no later than 1 May 2022.
Empros Pharma was founded in 2013 by researchers and entrepreneurs at Uppsala University together with the investor Flerie Invest. The company is developing EMP16, a pharmaceutical weight management treatment, planned to be ready for launch in 2027.
Pages
© 2025 empros pharma
Hemsidan är byggd av Weblab